Search

Your search keyword '"Hanazaki, Kazuhiro"' showing total 1,420 results
Start Over Author "Hanazaki, Kazuhiro"
1,420 results on '"Hanazaki, Kazuhiro"'

13. Impact of the hospital volume and setting on postoperative complications of surgery for gastroenterological cancers in a regional area of Western Japan

Author

Kunisawa, Susumu, Ishida, Haku, Ikai, Hiroshi, Nagano, Hiroaki, Fujiwara, Toshiyoshi, Ohdan, Hideki, Fujiwara, Yoshiyuki, Tajima, Yoshitsugu, Ueno, Tomio, Fujiwara, Yoshinori, Shimada, Mitsuo, Suzuki, Yasuyuki, Watanabe, Yuji, Hanazaki, Kazuhiro, Kakeji, Yoshihiro, Kumamaru, Hiraku, Takahashi, Arata, Miyata, Hiroaki, and Imanaka, Yuichi

Published
2023
Full Text
View/download PDF

14. Inflammatory prognostic factors in advanced or recurrent esophageal squamous cell carcinoma treated with nivolumab

Author

Ikoma, Tatsuki, Shimokawa, Mototsugu, Matsumoto, Toshihiko, Boku, Shogen, Yasuda, Tomoyo, Shibata, Nobuhiro, Kurioka, Yusuke, Takatani, Masahiro, Nobuhisa, Tetsuji, Namikawa, Tsutomu, Kitagawa, Hiroyuki, Hanazaki, Kazuhiro, Doi, Keitaro, Shimada, Takanobu, Tsumura, Takehiko, Marusawa, Hiroyuki, Kanaya, Seichiro, Morita, Shuko, Inokuma, Tetsurou, Nagai, Hiroki, Yasui, Hisateru, and Satake, Hironaga

Published
2023
Full Text
View/download PDF

18. Usefulness of an interprofessional work manual for perioperative glucose control of an artificial pancreas.

Author

Mibu, Kiyo, Kitagawa, Hiroyuki, Namikawa, Tsutomu, Maeda, Hiromichi, Fujisawa, Kazune, Munekage, Masaya, Yamasaki, Fumiyasu, Yamamoto, Nao, Seo, Satoru, and Hanazaki, Kazuhiro

Subjects
ARTIFICIAL pancreases, MANUAL labor, BLOOD sugar, BLOOD sampling, GLUCOSE
Abstract

Background: A closed‐loop bedside‐type artificial pancreas for perioperative glucose control has previously been introduced. However, artificial pancreas therapy was often interrupted due to continuous blood sampling failure. We developed an interprofessional work manual to reduce the interruption time of artificial pancreatic therapy for perioperative blood glucose control due to continuous blood sampling failure. This study aimed to investigate the usefulness of this manual. Methods: The manual consisted of the following sections: (1) the roles of the professionals in the preparation and management of the artificial pancreas, (2) how to address continuous blood sampling failure, and (3) checkpoints for interprofessional transfer of the artificial pancreas. We compared the results before the introduction of the manual and 2 years after the introduction of the manual. Results: There were 35 and 37 patients in the Before and After groups, respectively. There were no significant differences in patient backgrounds between the two groups, although there was significantly less blood loss in the After group (1164 vs. 366 mL; p < 0.001). The mean artificial pancreas therapy and artificial pancreas therapy interruption times were 847 min and 20 min, respectively. Artificial pancreas therapy interruption time (34 vs. 8 min; p = 0.078) and time per interruption (24 vs. 4 min; p < 0.001) were significantly shorter in the After group than in the Before group. Conclusions: The interprofessional working manual was useful in reducing the artificial pancreatic therapy interruption time for perioperative glucose control. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

21. 胃癌術後における血清亜鉛値の評価

Author

Namikawa, Tsutomu, primary, Tanaka, Tomoki, additional, Utsuomiya, Masato, additional, Yokota, Keiichiro, additional, Kawanishi, Yasuhiro, additional, Fujisawa, Kazune, additional, Munekage, Masaya, additional, Maeda, Hiromichi, additional, Kitagawa, Hiroyuki, additional, Kobayashi, Michiya, additional, Hanazaki, Kazuhiro, additional, and Seo, Satoru, additional

Published
2024
Full Text
View/download PDF

28. Impact of the COVID‐19 pandemic on short‐term outcomes after pancreaticoduodenectomy for pancreatic cancer: A retrospective study from the Japanese National Clinical Database, 2018–2021.

Author

Takemura, Yusuke, Endo, Hideki, Hibi, Taizo, Nakano, Yutaka, Seishima, Ryo, Takeuchi, Masashi, Yamamoto, Hiroyuki, Maeda, Hiromichi, Hanazaki, Kazuhiro, Taketomi, Akinobu, Kakeji, Yoshihiro, Seto, Yasuyuki, Ueno, Hideki, Mori, Masaki, and Kitagawa, Yuko

Subjects
COVID-19 pandemic, PANCREATIC cancer, PANCREATICODUODENECTOMY, PANCREATIC fistula, COVID-19, DATABASES, MEDICAL care
Abstract

Aim: The coronavirus disease 2019 (COVID‐19) pandemic greatly impacted medical resources such as cancer screening, diagnosis, and treatment given to people for various diseases. We surveyed the impacts of the pandemic on the incidence of complications and mortality following pancreaticoduodenectomy for pancreatic cancer in Japan. Methods: Data on patients who underwent pancreaticoduodenectomy for pancreatic cancer were extracted from the Japanese National Clinical Database (NCD) between 2018 and 2021. The number of the pancreaticoduodenectomy for pancreatic cancer were obtained and then the morbidity and mortality rates were evaluated using a standardized morbidity/mortality ratio (SMR), which is the ratio of the observed number of incidences to the expected number of incidences calculated by the risk calculator previously developed by the NCD. Results: This study included 22 255 cases. The number of pancreaticoduodenectomies exhibited an increasing trend even during the COVID‐19 pandemic. The mean observed incidence rates of Grade C pancreatic fistula and Clavien–Dindo grade ≥4 complications, and the 30‐day mortality and surgical mortality rates were 0.8%, 1.8%, 0.8% and 0.9%, respectively. The standardized morbidity ratios did not increase during the COVID‐19 pandemic. The standardized mortality ratios remained within the range of variations observed before the COVID‐19 pandemic. Conclusion: The increasing trend in the number of pancreaticoduodenectomies and favorable short‐term outcomes even in the COVID‐19 pandemic suggest the medical care for pancreatic cancer in Japan functioned well during the pandemic. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

29. Impact of the COVID‐19 pandemic on the number and short‐term outcomes in hepatectomy for hepatocellular carcinoma: Results from the Japanese National Clinical Database, 2018–2021.

Author

Takemura, Yusuke, Endo, Hideki, Hibi, Taizo, Nakano, Yutaka, Seishima, Ryo, Takeuchi, Masashi, Yamamoto, Hiroyuki, Maeda, Hiromichi, Hanazaki, Kazuhiro, Taketomi, Akinobu, Kakeji, Yoshihiro, Seto, Yasuyuki, Ueno, Hideki, Mori, Masaki, and Kitagawa, Yuko

Subjects
COVID-19 pandemic, DATABASES, HEPATECTOMY, COVID-19, INTENSIVE care units, LIVER surgery, HEPATOCELLULAR carcinoma
Abstract

Aim: The coronavirus disease 2019 (COVID‐19) pandemic has significantly impacted the allocation of medical resources, including cancer screening, diagnosis, and treatment. We aimed to investigate the effects of the pandemic on morbidity and mortality following hepatectomy for hepatocellular carcinoma (HCC). Methods: We identified patients who underwent hepatectomy for HCC between 2018 and 2021 from the Japanese National Clinical Database (NCD). The number of surgical cases, the use of intensive care units, and the incidence of morbidity were assessed. The standardized morbidity / mortality ratio (SMR) was used to evaluate the rates of morbidity (bile leakage and pneumonia) and mortality in each month, which compares the observed incidence to the expected incidence calculated by the NCD's risk calculator. Results: The study included a total of 10 647 cases. The number of patients undergoing hepatectomy for HCC gradually decreased. The proportion of patients aged 80 years or older increased and that of cases with T1 stage decreased. The proportion of patients who were admitted to the intensive care unit did not change between the pre‐ and postpandemic period. The mean actual incidence rates of bile leakage, pneumonia, 30‐day mortality, and surgical mortality were 9.2%, 2.3%, 1.4%, and 2.1%, respectively. The SMR for the mortalities and morbidities in each month did not increase mostly throughout the COVID‐19 pandemic. Conclusions: The present study showed the decreasing number of resected cases for HCC, while the surgical safety for hepatectomy was enough to be maintained by managing medical resources in Japan. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

45. Immunohistochemically Detected Expression of ATRX, TSC2, and PTEN Predicts Clinical Outcomes in Patients With Grade 1 and 2 Pancreatic Neuroendocrine Tumors

Author

Uemura, Jun, Okano, Keiichi, Oshima, Minoru, Suto, Hironobu, Ando, Yasuhisa, Kumamoto, Kensuke, Kadota, Kyuichi, Ichihara, Shuji, Kokudo, Yasutaka, Maeba, Takashi, Nanno, Yoshihide, Toyama, Hirochika, Takada, Yasutsugu, Shimada, Mitsuo, Hanazaki, Kazuhiro, Masaki, Tsutomu, and Suzuki, Yasuyuki

Published
2021
Full Text
View/download PDF

46. Gastric cancer with Fanconi anemia in adolescent and young adult patient diagnosed by comprehensive genome profiling using next-generation sequencing

Author

Namikawa, Tsutomu, primary, Tanaka, Tomoki, additional, Utsunomiya, Masato, additional, Yokota, Keiichiro, additional, Munekage, Masaya, additional, Maeda, Hiromichi, additional, Kitagawa, Hiroyuki, additional, Kurioka, Yusuke, additional, Satake, Hironaga, additional, Kobayashi, Michiya, additional, Hanazaki, Kazuhiro, additional, and Seo, Satoru, additional

Published
2023
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results